Rozenberg & Co provides financing, restructuring and other investment banking advice including M&A facilitation, term-sheet negotiations and investor introductions.
Fund Management
All Rights Reserved.
QBF Pty Ltd, Brisbane, Australia
Snr Investment Manager : Nov ’03 - Dec ‘08
QBF is a $100m 10-year closed-end life sciences venture capital fund. It is a subsidiary of QIC, a $80bn funds manager.
BIO-IB LLC NYC, USA
Senior Advisor : since 2007
Bio-IB is a US based healthcare investment banking group with a focus on small to mid-sized biotechs. Capital raisings, M&A transactions, corporate advisory and strategic consultation is provided worldwide.
Innovis Investments LLC, Brisbane, Australia and Irvine, CA, USA
Senior Associate : Dec’04 – Nov’08
Innovis Investments LLC, a US-AUS pan-pacific fund, focusing on private and micro-cap public companies in Biotechnology, Pharmaceuticals and Healthcare.
Genacys Ltd, UK
Investment & Technology Manager : 2001-2003
Open ended materials and chemistry investment fund wholly owned by Whyte Chem Ltd. Gregor Rozenberg managed an open-ended private fund and achieved 30-fold value increase during my tenure as a direct investor in technology SMEs and IP portfolios.
Aquila BioScience Ventures, Brisbane and NYC, Australia and USA
Venture Partner : since 2009
Aquila is a venture fund focused on financing and developing mature clinical stage assets. Special Purpose companies house in-licensed rights to commercialise IP, regulatory and clinical packages. Dormant.
Petrus Capital, Brisbane and Sydney, Australia
Founding Partner : since 2008
Venture fund focused on financing through debt tools. Dormant.
We provide valuation services, due diligence assistance, pitch preparation, Investment Memorandum and Business Plan writing. Furthermore, we advice on portfolio construction and fund-life management. As an independent consultant, we make an impartial review of assets. This assessment can guide and enable constructive decision making.*
Rozenberg & Co has provided advice to several global venture and hedge funds with the focus on hightech life-sciences projects and companies.
Below is a list of engagements and positions which are in the public domain.
* Any recipient must make its own independent assessment and investigation of the information and should not rely on any statement contained in any advice as to the significance, adequacy or accuracy of any matter described. Rozenberg & Co makes no representation or warranty as to the accuracy, reliability or completeness of any information subsequently provided to the recipient or its advisers. Rozenberg & Co and their respective directors, employees, agents, advisers and consultants have no liability (including liability to any person by reason of negligence or negligent misstatement) for any statements, opinions, information or matters (expressed or implied) arising out of, contained in or derived from, or for any omission from, the information provided to the recipient or its advisers, except liability under statute that cannot be excluded. Rozenberg & Co is not licensed to provide mortgage, superannuation, annuities, pensions or any other personal financial advice. We provide services to sophisticated investors, fund managers, investment banks and corporations that are AFSL authorised.
Vitae